150 related articles for article (PubMed ID: 22843046)
21. Meta-analysis demonstrates no association between p53 codon 72 polymorphism and prostate cancer risk.
Li MS; Liu JL; Wu Y; Wang P; Teng H
Genet Mol Res; 2011 Nov; 10(4):2924-33. PubMed ID: 22179964
[TBL] [Abstract][Full Text] [Related]
22. Association of TP53 Codon 72 Arg>Pro Polymorphism with Breast and Lung Cancer Risk in the South Asian Population: A Meta-Analysis.
Jafrin S; Aziz MA; Anonna SN; Akter T; Naznin NE; Reza S; Islam MS
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1511-1519. PubMed ID: 32592343
[TBL] [Abstract][Full Text] [Related]
23. Updated meta-analysis of the TP53 Arg72Pro polymorphism and gastric cancer risk.
Xiang B; Mi YY; Li TF; Liu PF
Asian Pac J Cancer Prev; 2012; 13(5):1787-91. PubMed ID: 22901123
[TBL] [Abstract][Full Text] [Related]
24. P53 Arg72Pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in Asians but not Caucasians.
Xu T; Xu ZC; Zou Q; Yu B; Huang XE
Asian Pac J Cancer Prev; 2012; 13(5):2349-54. PubMed ID: 22901221
[TBL] [Abstract][Full Text] [Related]
25. P53 codon 72 Arg/Pro polymorphism and glioma risk: an updated meta-analysis.
He F; Xia Y; Liu H; Li J; Wang C
Tumour Biol; 2013 Oct; 34(5):3121-30. PubMed ID: 23860773
[TBL] [Abstract][Full Text] [Related]
26. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.
Liu ZH; Bao ED
Mol Biol Rep; 2013 Mar; 40(3):2389-95. PubMed ID: 23184052
[TBL] [Abstract][Full Text] [Related]
27. Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis.
Wang B; Wang D; Zhang D; Li A; Liu D; Liu H; Jin H
Eur J Cancer Prev; 2010 Jul; 19(4):299-307. PubMed ID: 20389250
[TBL] [Abstract][Full Text] [Related]
28. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study.
Sümbül AT; Akkız H; Bayram S; Bekar A; Akgöllü E; Sandıkçı M
Mol Biol Rep; 2012 Feb; 39(2):1639-47. PubMed ID: 21607615
[TBL] [Abstract][Full Text] [Related]
29. Association between p53 polymorphism at codon 72 and recurrent spontaneous abortion.
Zhang Y; Wu YY; Qiao FY; Zeng WJ
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):402-405. PubMed ID: 27376811
[TBL] [Abstract][Full Text] [Related]
30. Increased risk of cutaneous melanoma associated with p53 Arg72Pro polymorphism.
Geng P; Liao Y; Ruan Z; Liang H
PLoS One; 2015; 10(3):e0118112. PubMed ID: 25774791
[TBL] [Abstract][Full Text] [Related]
31. p53 codon 72 polymorphism and endometriosis: a meta-analysis.
Jia S; Xu L; Chan Y; Wu X; Yang S; Yu H; Yang H; Luo Y; Tang W
Arch Gynecol Obstet; 2012 Jun; 285(6):1657-61. PubMed ID: 22258307
[TBL] [Abstract][Full Text] [Related]
32. Arg72Pro polymorphism of TP53 gene and the risk of skin cancer: a meta-analysis.
Ye J; Li XF; Wang YD; Yuan Y
PLoS One; 2013; 8(11):e79983. PubMed ID: 24260330
[TBL] [Abstract][Full Text] [Related]
33. Association between MDM2 SNP309, p53 Arg72Pro, and hepatocellular carcinoma risk: A MOOSE-compliant meta-analysis.
Duan X; Li J
Medicine (Baltimore); 2017 Sep; 96(36):e7856. PubMed ID: 28885338
[TBL] [Abstract][Full Text] [Related]
34. TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis.
Jiang DK; Yao L; Ren WH; Wang WZ; Peng B; Yu L
Med Oncol; 2011 Dec; 28(4):1129-35. PubMed ID: 20552298
[TBL] [Abstract][Full Text] [Related]
35. MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.
Wan Y; Wu W; Yin Z; Guan P; Zhou B
BMC Cancer; 2011 May; 11():208. PubMed ID: 21619694
[TBL] [Abstract][Full Text] [Related]
36. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.
Mostaid MS; Ahmed MU; Islam MS; Bin Sayeed MS; Hasnat A
Tumour Biol; 2014 Oct; 35(10):10309-17. PubMed ID: 25034526
[TBL] [Abstract][Full Text] [Related]
37. No Evidence of Association of the Arg72Pro p53 Gene Polymorphism with Cancer Risk in the Saudi Population: a Meta-Analysis.
Irshad M; Mandal RK; Al-Drees A; Khalil MS; Abdulghani HM
Asian Pac J Cancer Prev; 2015; 16(14):5663-7. PubMed ID: 26320432
[TBL] [Abstract][Full Text] [Related]
38. Genetic polymorphism of p53, but not GSTP1, is association with susceptibility to esophageal cancer risk - a meta-analysis.
Zhao Y; Wang F; Shan S; Zhao Y; Qiu X; Li X; Jiao F; Wang J; Du Y
Int J Med Sci; 2010 Sep; 7(5):300-8. PubMed ID: 20827430
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis of association between the TP53 Arg72Pro polymorphism and risk of endometriosis based on case-control studies.
Yan Y; Wu R; Li S; He J
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():1-7. PubMed ID: 25819169
[TBL] [Abstract][Full Text] [Related]
40. Evaluating the association between p53 codon 72 Arg>pro polymorphism and risk of ovary cancer: a meta-analysis.
Alqumber MA; Akhter N; Haque S; Panda AK; Mandal RK
PLoS One; 2014; 9(4):e94874. PubMed ID: 24747975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]